• Markets
    • icon
  • Companies
CAJ · ASX

Capitol Health Limited (ASX:CAJ)

AU$0.21

 0.0 (0.0%)
ASX:Live
01/12/2023 04:10:47 PM
HALO Ords GROWTH AUS ASR Trading Report - All All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CAJ Overview

CAJ Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About CAJ

Website

Capitol Health Limited

Telephone

61.3.9348.3333

Address

Level 2 288 Victoria Parade East Melbourne, Victoria (VIC) 3002

Description

Capitol Health Ltd. provides diagnostic imaging and related services. It provides general x-ray, magnetic resonance imaging, ultrasound, mammography, doppler, orthopantomogram, echocardiography, computer tomography, computed tomography angiography, cone beam computed tomography, nuclear medicine, bone densitomety, and fluoroscopy services. The company was founded by Andrew Duncan Harrison on December 1, 2005 and is headquartered in Docklands, Australia.

CAJ Price Chart

Key Stats

Market Cap

AU$229.15M

PE

31.90

EV/EBITDA

7.9

Dividends Overview

DIV Yield

3.8%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.19 - 0.33

Trade Value (12mth)

AU$80,207.00

1 week

0%

1 month

13.51%

YTD

-33.33%

1 year

-34.38%

All time high

1.11

Key Fundamentals

EPS 3 yr Growth

-1081.800%

EBITDA Margin

19.20%

Operating Cashflow

$38m

Free Cash Flow Return

15.50%

ROIC

-4.70%

Interest Coverage

7.80

Quick Ratio

0.60

Other Data

Shares on Issue (Fully Dilluted)

1061m

HALO Sector

Healthcare

Next Company Report Date

28-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.01

CAJ Announcements

Latest Announcements

Date Announcements

31 March 22

Becoming a substantial holder from MQG

×

Becoming a substantial holder from MQG

31 July 23

FY23 Financial Results Release Date

×

FY23 Financial Results Release Date

31 August 23

Extension of Voluntary Escrow Period

×

Extension of Voluntary Escrow Period

31 August 22

Ceasing to be a substantial holder from MUFG

×

Ceasing to be a substantial holder from MUFG

30 September 11

2011 Annual Report

×

2011 Annual Report

30 September 10

2010 Annual Report

×

2010 Annual Report

30 August 23

Notification of cessation of securities - CAJ

×

Notification of cessation of securities - CAJ

30 August 22

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

29 October 07

Annual Report to shareholders

×

Annual Report to shareholders

29 October 07

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 November 17

Presentation - Capitol's Offer for Integral Diagnostics

×

Presentation - Capitol's Offer for Integral Diagnostics

29 March 22

Change in substantial holding

×

Change in substantial holding

29 February 08

Half Year Results Presentation

×

Half Year Results Presentation

29 August 16

Annual Report

×

Annual Report

29 August 16

Market Presentation

×

Market Presentation

28 September 23

Release of Securities from Voluntary Escrow

×

Release of Securities from Voluntary Escrow

28 September 22

Update - Dividend/Distribution - CAJ

×

Update - Dividend/Distribution - CAJ

28 September 12

2012 Annual Report

×

2012 Annual Report

28 October 09

Annual Report to shareholders

×

Annual Report to shareholders

28 October 09

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

28 June 23

Trading and Business Update

×

Trading and Business Update

28 February 17

Market Presentation - Results, Capital Raising and SPP

×

Market Presentation - Results, Capital Raising and SPP

28 August 23

Section 708A Cleansing Statement

×

Section 708A Cleansing Statement

28 August 23

Application for quotation of securities - CAJ

×

Application for quotation of securities - CAJ

28 August 23

Change of Director's Interest Notice

×

Change of Director's Interest Notice

28 August 23

Change in substantial holding from WAM, WMI,WAX

×

Change in substantial holding from WAM, WMI,WAX

28 August 23

Release of Securities from Escrow

×

Release of Securities from Escrow

28 August 18

Appendix 4E and FY2018 Annual Report

×

Appendix 4E and FY2018 Annual Report

CAJ Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 963.6 -11.1 -203.8 Lock Lock Lock
     PE X Lock Lock Lock Lock 27.7 24.7 31.9 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 10.2 7.9 7.9 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.04 0.04 0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.02 0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 60.6 -14.2 -9.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock 4.8 3.1 3.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.01 0.01 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 2.4 3.1 3.8 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 85 96 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.14 0.15 0.13 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.02 0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.1 39.7 -230.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,053 1,060 1,054 Lock Lock Lock
Basic m Lock Lock Lock Lock 1,020 1,036 1,054 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 178 184 210 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.7 3.5 13.8 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 18 18 22 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 45 38 37 Lock Lock Lock
     Growth % Lock Lock Lock Lock 64.2 -14.0 -2.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 25.0 20.8 17.8 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 75 79 82 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 48 41 40 Lock Lock Lock
     Growth % Lock Lock Lock Lock 32.1 -14.4 -2.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 27.0 22.3 19.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 21 21 25 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 27 20 15 Lock Lock Lock
     Growth % Lock Lock Lock Lock 157.7 -24.6 -23.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock 15.0 10.9 7.4 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 19 16 -10 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 7 5 1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 12 11 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 1,277.9 -10.0 -206.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.7 5.8 -5.4 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 41 33 38 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 8 13 17 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -21 -15 -63 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -12 -26 31 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 33 20 21 Lock Lock Lock
     Growth % Lock Lock Lock Lock 43.0 -39.7 5.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.2 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 22 13 19 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 280 271 318 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 84 71 123 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 72 68 116 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 134 117 180 Lock Lock Lock
Equity $m Lock Lock Lock Lock 146 153 137 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 230 224 261 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.7 -2.7 16.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 4.3 4.0 -3.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 8.2 7.0 -8.3 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 11.1 8.4 6.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 5.2 4.7 -4.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 17.8 14.5 15.5 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 14.2 14.0 7.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.5 1.6 2.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 49.6 44.3 84.6 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 0.8 0.6 0.6 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.8 0.6 0.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 77.2 66.6 69.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 109.1 98.0 77.6 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 31.9 32.2 35.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.7 1.7 3.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.6 0.7 0.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.6 0.7 0.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 10.9 8.7 -4.8 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 7.0 5.9 -3.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 38.1 31.2 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 4.3 4.0 -3.6 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.9 1.8 2.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 8.2 7.0 -8.3 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 14.5 3.8 192.6 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 1.2 0.3 -16.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 11.4 11.4 10.3 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 11.4 11.4 10.3 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 3.2 5.4 12.1 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 8.2 5.9 -1.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

3.8%

Franking Level

100%

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.01%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

-0.20%

3 Month Change

-0.20%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

CAJ Shortsell

Frequently Asked Questions

The current share price of Capitol Health Limited (CAJ:ASX) is AU$0.21.
The 52-week high share price for Capitol Health Limited (CAJ:ASX) is AU$0.33.
The 52-week low share price for Capitol Health Limited (CAJ:ASX)? is AU$0.19.
The current TTM dividend payout for Capitol Health Limited (CAJ:ASX) is 3.80.
The last dividend payment of Capitol Health Limited (CAJ:ASX) is AU$0.01.
Capitol Health Limited (CAJ:ASX) has a franking level of 100%.
Capitol Health Limited (CAJ:ASX) is classified in the Healthcare.
The current P/E ratio for Capitol Health Limited (CAJ:ASX) is 31.90.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.